ToddMDurellMD

PubMed

• 15 citations
  Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study
  Lenard A. Adler, David B. Clemow, David Wynne Williams, Todd M. Durell> ;Plos One. 2014 Aug 22
• 14 citations
  Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: A pilot project
  Andrew F. Leuchter, James J. McGough, Alexander S. Korb, Aimee M. Hunter, Paul E.A. Glaser, Ahmed Deldar, Todd M. Durell, Ian A. Cook> ;Journal of Psychiatric Research. 2014 Jul 1
• 42 citations
  A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder
  Himanshu P. Upadhyaya, Durisala Desaiah, Kory Schuh, Frank P. Bymaster, Mary Jeanne Kallman, Clarke David O, Todd M. Durell, Paula T. Trzepacz, David O. Calligaro, Eri...> ;Psychopharmacology. 2013 Feb 9
• 45 citations
  Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlle...
  Todd M. Durell, Lenard A. Adler, Dave W. Williams, Ahmed Deldar, James J. McGough, Paul E.A. Glaser, Richard L. Rubin, Teresa A. Pigott, Elias Sarkis, Bethany K. Fox> ;Journal of Clinical Psychopharmacology. 2013 Feb 1
• 6 citations
  Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled Analysis
  Lenard A. Adler, Timothy E. Wilens, Shuyu Zhang, Ralf W. Dittmann, Deborah N. D'Souza, Leslie M. Schuh, Todd M. Durell> ;Clinical Therapeutics. 2012 Feb 1
• 2 citations
  Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted i...
  Elisabeth K. Degenhardt, Jorge M. Tamayo, Hassan H. Jamal, Jennifer Gatz, Mauricio Tohen, Todd M. Durell> ;International Clinical Psychopharmacology. 2011 May 1
• 18 citations
  Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder.
  Virginia L. Stauffer, Jennifer Sniadecki, Kevin W Piezer, Jennifer Gatz, Sara Kollack-Walker, Vicki Poole Hoffmann, Robert R. Conley, Todd M. Durell> ;BMC Psychiatry. 2010 Nov 3
• 26 citations
  Stimulant Formulation and Motivation for Nonmedical Use of Prescription Attention‐Deficit/Hyperactivity Disorder Medications in a College‐Aged Population
  Himanshu P. Upadhyaya, Larry A. Kroutil, Deborah Deas, Todd M. Durell, David L. Van Brunt, Scott P. Novak> ;The American Journal on Addictions. 2010 Nov 1
• 34 citations
  Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall ...
  Mauricio Tohen, Michael Case, Madhukar H. Trivedi, Michael E. Thase, Scott J. Burke, Todd M. Durell> ;The Journal of Clinical Psychiatry. 2010 Feb 23
• 13 citations
  Atomoxetine Treatment for ADHD: Younger Adults Compared with Older Adults.
  Todd M. Durell, Lenard A. Adler, Timothy E. Wilens, Martin Paczkowski, Kory Schuh> ;Journal of Attention Disorders. 2010 Jan 1
• 92 citations
  Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
  Lenard A. Adler, Michael Liebowitz, William G. Kronenberger, Meihua Qiao, Richard Rubin, B S Millie Hollandbeck, Ahmed Deldar, Kory Schuh, Todd Durell> ;Depression and Anxiety. 2009 Mar 1
• 15 citations
  Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder.
  Todd M. Durell, Andres J. Pumariega, Eugenio M. Rothe, Jorge M. Tamayo, David Baron, David A. Williams> ;Annals of Clinical Psychiatry. 2009 Jan 1
• 30 citations
  Prevalence of nonmedical methamphetamine use in the United States.
  Todd M. Durell, Larry A. Kroutil, Paul Crits-Christoph, Nina Barchha, David L. Van Brunt> ;Substance Abuse Treatment, Prevention, and Policy. 2008 Jul 25
• 15 citations
  Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder.
  Jorge M. Tamayo, Andres J. Pumariega, Eugenio M. Rothe, Douglas Kelsey, Albert J. Allen, Jesus Velez-Borras, David A. Williams, Susan G. Anderson, Todd M. Durell> ;Journal of Child and Adolescent Psychopharmacology. 2008 Feb 24
• 32 citations
  Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
  Joshua A. Lile, William W. Stoops, Todd M. Durell, Paul E.A. Glaser, Craig R. Rush> ;Experimental and Clinical Psychopharmacology. 2006 May 1
• 18 citations
  Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence.
  Lenard A. Adler, Timothy E. Wilens, Shuyu Zhang, Todd M. Durell, Daniel J. Walker, Leslie M. Schuh, Ling Jin, Peter D. Feldman, Paula T. Trzepacz> ;The American Journal on Addictions. 2009 Oct 29
• Join now to see all